Amylin deposition in the brain of Parkinson’s disease patients
Objective: The objective of this study was to determine the presence of amylin deposits in the brain of subjects with synucleinopathies. Background: The link between…Predictors of Retention for Carbidopa/Levodopa Intestinal Gel in Parkinson Disease
Objective: To identify predictors of discontinuation of levodopa/carbidopa intestinal gel therapy. Background: Although levodopa/carbidopa intestinal gel (LCIG) is an established treatment for Parkinson's disease complicated…Parkinson’s Disease Presentation in Calabar, Nigeria
Objective: To create a database and describe the presentation of Parkinson's disease patients at the sole tertiary hospital in Calabar, southern Nigeria. Background: Parkinson's disease…Unraveling biological processes implicated in MSA and PD by transcriptomic analysis
Objective: To find differential biological processes between synucleinopathies (MSA and PD). Background: Multiple system atrophy (MSA) is an oligodendroglial sinucleinopathy that is often misdiagnosed as…Braak model in Parkinson disease using MRI biomarkers
Objective: The aim of this study was to test using multimodal MRI biomarkers if the pattern of neurodegeneration in the brain of patients with PD…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.